Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Anjali Kusumbe has been awarded an MRC Career Development Award to support her research examining how blood vessels support bone growth and repair.

The prestigious five-year MRC Career Development Award is designed to support talented early stage scientists as they transition to become independent investigators. The award will allow Anjali to pursue an ambitious programme of research aimed at understanding how blood vessels might be targeted to stimulate new bone growth in disease.

Bone is maintained through a delicate balance between breakdown of existing tissue and formation of new bone by cells called osteoblasts. During aging, however, new bone formation becomes less efficient, increasing risk of fractures and other musculoskeletal disorders.

Anjali's previous research as a postdoctoral fellow at the Max Plank Institute, Germany identified a certain type of endothelial cells in blood vessels that create a nurturing environment for bone progenitors. Experimental activation of these endothelial cells could increase bone mass during aging.

Anjali now wants to better understand the signals and cell types that mediate communication between blood vessels and stem/progenitor cells. She hopes this will lead to new strategies to manipulate bone growth and turnover.

Speaking of her award, Anjali said: "It is crucial to improve our understanding of the bone marrow microenvironment in order to identify startegies to treat bone diseases. I'm really excited. Getting an MRC Career Development Award acknowledges the fact that the project is good enough to be financed externally".

Anjali joined the Kennedy Institute in July 2016 supported by funds from the Kennedy Trust for Rheumatology Research.

Similar stories

MRC funding awarded to Kennedy researchers

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

New research suggests targeting blood vessels could be key to controlling fibrotic disease

By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.